Cancer patients share their treatment stories
NCT ID NCT07008963
Summary
This study aimed to learn directly from patients about their experiences taking a specific drug combination (capivasertib + fulvestrant) for advanced breast cancer. Researchers interviewed 48 people who had taken the treatment to understand their attitudes, dosing experiences, and how well they could tolerate it. The goal was to gather real-world insights to help improve future patient care and support.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Redwood Shores, California, 94065, United States
Conditions
Explore the condition pages connected to this study.